Phase II-III Clinical Development

According to the characteristics of drugs and development plans, we match more suitable leading PIs, leading sites, investigators, and sub-centers by taking into account the academic influence, project competitiveness, and experience in large-scale clinical trials. We explore and expand patient recruitment sources through multiple channels, comprehensively control project quality management and risks, and assist the quick application to authorities for the products.

Read Our Perspectives
Your R&D Needs